| [13] |
Brown SM, Jampol LM, Cantrill HL. Intraocular lymphoma presenting as retinal vasculitis[J]. Surv Ophthalmol, 1994, 39(2)：133-140.
|
| [14] |
Katoch D, Bansal R, Nijhawan R, et al. Primary intraocular central nervous system lymphoma masquerading as diffuse retinal vasculitis[J]. BMJ Case Rep, 2013: 9354.
|
| [15] |
Hedayatfar A, Phaik Chee S. Presumptive primary intraocular lymphoma presented as an intraocular mass involving the optic nerve head[J]. J Ophthalmic Inflamm Infect, 2012, 2(1): 49-51.
|
| [16] |
Araujo I, Coupland SE. Primary Vitreoretinal Lymphoma-A Review[J]. Asia Pac J Ophthalmol (Phila), 2017, 6(3): 283-289.
|
| [17] |
Velez G, Chan CC, Csaky KG. Fluorescein angiographic findings in primary intraocular lymphoma[J]. Retina, 2002, 22(1): 37-43.
|
| [18] |
Fardeau C, Lee CP, Merle-Béral H, et al. Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin primary intraocular lymphoma[J]. Am J Ophthalmol, 2009, 147(5): 886-894.
|
| [19] |
Casady M, Faia L, Nazemzadeh M, et al. Fundus autofluorescence patterns in primary intraocular lymphoma[J]. Retina, 2014, 34(2): 366-372.
|
| [20] |
Egawa M, Mitamura Y, Hayashi Y, et al. Spectral-domain optical coherence tomographic and fundus autofluorescence findings in eyes with primary intraocular lymphoma[J]. Clin Ophthalmol, 2014, 8: 335-341.
|
| [21] |
赵慧英，管文雪，马雅，等. 原发性玻璃体视网膜淋巴瘤患眼光相干断层扫描图像特征[J]. 中华眼底病杂志，2021，37(2)：133-137.
|
| [22] |
Saito T, Ohguro N, Iwahashi C, et al. Optical coherence tomography manifestations of primary vitreoretinal lymphoma[J]. Graefes Arch Clin Exp Ophthalmol, 2016, 254(12): 2319-2326.
|
| [23] |
Deák GG, Goldstein DA, Zhou M, et al. Vertical Hyperreflective Lesions on Optical Coherence Tomography in Vitreoretinal Lymphoma[J]. JAMA Ophthalmol, 2019, 137(2): 194-198.
|
| [24] |
Barry RJ, Tasiopoulou A, Murray PI, et al. Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis[J]. Br J Ophthalmol, 2018, 102(10): 1362-1366.
|
| [25] |
DeAngelis LM. Primary central nervous system lymphoma[J]. Curr Opin Neurol, 1999, 12(6): 687-691.
|
| [26] |
Coupland SE, Perez-Canto A, Hummel M, et al. Assessment of HOPE fixation in vitrectomy specim ens in patients with chronic bilateral uveitis (masquerade syndrome)[J]. Graefes Arch Clin Exp Ophthalmol, 2005, 243(9): 847-852.
|
| [27] |
Chan CC, Wallace DJ. Intraocular lymphoma: update on diagnosis and management[J]. Cancer Control, 2004, 11(5): 285-295.
|
| [28] |
Kimura K, Usui Y, Goto H. Japanese Intraocular Lymphoma Study Group. Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma[J]. Jpn J Ophthalmol, 2012, 56(4): 383-389.
|
| [29] |
Lai J, Chen K, Shi HM, et al. B-scan ultrasound and cytology of the vitreous in primary central nervous system lymphoma with vitreoretinal involvement[J]. Int J Ophthalmol, 2019, 12(6): 1001-1007.
|
| [30] |
Pochat-Cotilloux C, Bienvenu J, Nguyen AM, et al. Use of a threshold of interleukin-10 and il-10/il-6 ratio in ocular samples for the screening of vitreoretinal lymphoma[J]. Retina, 2018, 38(4): 773-781.
|
| [31] |
Lee J, Kim SW, Kim H, et al. Differential diagnosis for vitreoretinal lymphoma with vitreoretinal findings, immunoglobulin clonality tests and interleukin levels[J]. Retina, 2019, 39(6): 1165-1176.
|
| [32] |
De Hoog J, Dik WA, Lu L, et al. Combined cellular and soluble mediator analysis for improved diagnosis of vitreoretinal lymphoma[J]. Acta Ophthalmol, 2019, 97(6): 626-632.
|
| [33] |
Kuo DE, Wei MM, Knickelbein JE, et al. Logistic Regression Classification of Primary Vitreoretinal Lymphoma versus Uveitis by Interleukin 6 and Interleukin 10 Levels[J]. Ophthalmology, 2020, 127(7): 956-962.
|
| [34] |
Kawamura H, Yasuda N, Kakinoki M, et al. Interleukin-10 and interleukin-6 in aqueous humor during treatment of vitreoretinal lymphoma with intravitreally injected methotrexate[J]. Ophthalmic Res, 2009, 42(3): 172-174.
|
| [35] |
Kuiper J, Ten Dam-van Loon N, Domanian A, et al. Correlation between measurement of IL-10 and IL-6 in paired aqueous humour and vitreous fluid in primary vitreoretinal lymphoma[J]. Acta Ophthalmol, 2015, 93(8): e680-681.
|
| [36] |
Cassoux N, Giron A, Bodaghi B, et al. IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma[J]. Invest Ophthalmol Vis Sci, 2007, 48(7): 3253-3259.
|
| [37] |
Wolf LA, Reed GF, Buggage RR, et al. Vitreous cytokine levels[J]. Ophthalmology, 2003, 110(8): 1671-1672.
|
| [38] |
Wang Y, Shen D, Wang VM, et al. Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma[J]. Int J Mol Sci, 2011, 12(9): 5684-5697.
|
| [39] |
Costopoulos M, Touitou V, Golmard JL, et al. ISOLD: A New Highly Sensitive Interleukin Score for Intraocular Lymphoma Diagnosis[J]. Ophthalmology, 2016, 123(7): 1626-1628.
|
| [40] |
Chen K, Li X, Wang D, et al. The diagnostic value of IL-10 and IL-6 level in vitreous fluid and aqueous humor for vitreoretinal lymphoma[J]. Clin Chim Acta, 2021, 515: 21-26.
|
| [41] |
Missotten T, Tielemans D, Bromberg JE, et al. Multicolor flowcytometric immunophenotyping is a valuable tool for detection of intraocular lymphoma[J]. Ophthalmology, 2013, 120(5): 991-996.
|
| [42] |
Davis JL, Viciana AL, Ruiz P. Diagnosis of intraocular lymphoma by flow cytometry[J]. Am J Ophthalmol, 1997, 124(3): 362-372.
|
| [43] |
Chan CC. Molecular pathology of primary intraocular lymphoma[J]．Trans Am Ophthalmol Soc, 2003, 101: 275-292.
|
| [44] |
Merle-Béral H, Davi F, Cassoux N, et al. Biological diagnosis of primary intraocular lymphoma[J]. Br J Haematol, 2004, 124: 469-473.
|
| [1] |
Grimm SA, Pulido JS, Jahnke K, et al. Primary intraocular lymphoma: an InternationalPrimary Central Nervous System Lymphoma Collaborative Group Report[J]. Ann Oncol, 2007, 18(11): 1851-1855.
|
| [2] |
Grimm SA, McCannel CA, Omuro AM, et al. Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report[J]. Neurology, 2008, 71(17): 1355-1360.
|
| [3] |
Hormigo A, Abrey L, Heinemann MH, et al. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment[J]. Br J Haematol, 2004, 126(2): 202-208.
|
| [4] |
Whitcup SM, de Smet MD, Rubin BI, et al. Intraocular lymphoma: Clinical and histopathologic diagnosis[J]. Ophthalmology, 1993, 100(9): 1399-1406.
|
| [5] |
Kalogeropoulos D, Vartholomatos G, Mitra A, et al. Primary vitreoretinal lymphoma[J]. Saudi J Ophthalmol, 2019, 33(1): 66-80.
|
| [6] |
Zhao XY, Cheng TT, Meng LH, et al. Clinical Features, Diagnosis, Management and Prognosis of Primary Intraocular Lymphoma[J]. Front. Oncol, 2022, 12: 808511.
|
| [7] |
Meunier J, Lumbroso-Le Rouic L, Vincent-Salomon A, et al. Ophthalmologic and intraocular non-Hodgkin's lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factors[J]. Hematol Oncol, 2004, 22(4): 143-158.
|
| [8] |
Coupland SE, Damato B. Understanding intraocular lymphomas[J]. Clin Exp Ophthalmol, 2008, 36(6): 564-578.
|
| [9] |
Chan CC, Sen HN. Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma[J]. Discov Med, 2013, 15(81): 93-100.
|
| [10] |
AlQahtani A, Touitou V, Cassoux N, et al. More than a masquerade syndrome: atypical presentations of vitreoretinal lymphomas[J]. Ocul Immunol Inflamm, 2014, 22(3): 189-196.
|
| [11] |
Chan CC, Rubenstein JL, Coupland SE, et al. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium[J]. Oncologist, 2011, 16(11): 1589-1599.
|
| [12] |
Faia LJ, Chan CC. Primary intraocular lymphoma[J]. Arch Pathol Lab Med, 2009, 133(8): 1228-1232.
|
| [45] |
Lobo A, Okhravi N, Adamson P, et al. Protocol for the use of polymerase chain reaction in the detection of intraocular large B-cell lymphoma in ocular samples[J]. J Mol Diagn, 2007, 9: 113-121.
|
| [46] |
Narasimhan S, Joshi M, Parameswaran S, et al. MYD88 L265P mutation in intraocular lymphoma: A potential diagnostic marker[J]. Indian J Ophthalmol, 2020, 68(10): 2160-2165.
|
| [47] |
Bonzheim I, Giese S, Deuter C, et al. High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates[J]. Blood, 2015, 126(1): 76-79.
|
| [48] |
Hiemcke-Jiwa LS, Ten Dam-van Loon NH, Leguit RJ, et al. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction[J]. JAMA Ophthalmol, 2018, 136(10): 1098-1104.
|
| [49] |
Yonese I, Takase H, Yoshimori M, et al. CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential[J]. Eur J Haematol, 2019, 102(2): 191-196.
|
| [50] |
Carbonell D, Mahajan S, Chee SP, et al. Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma[J]. Ocul Immunol Inflamm, 2021, 29(3): 507-520.
|
| [51] |
Sugita S, Takase H, Sugamoto Y, et al. Diagnosis of intraocular lymphoma by polymerase chain reaction analysis and cytokine profiling of the vitreous fluid[J]. Jpn J Ophthalmol, 2009, 53(3): 209-214.
|
| [52] |
Tanaka R, Kaburaki T, Taoka K, et al. More accurate diagnosis of vitreoretinal lymphoma using a combination of diagnostic test results: a prospective observational study[J]. Ocul Immunol Inflamm, 2021: 1873394.
|